Table 2.
Characteristics of Patients with FIGO Stage III (2018)
| Characteristics | No. (100%) |
|---|---|
| Total | 586 |
| Age (years old) | |
| Median: 50 | |
| <30 | 9 (1.5%) |
| 30–39 | 43 (7.3%) |
| 40–49 | 223 (38.1%) |
| 50–59 | 210 (35.8%) |
| 60–69 | 80 (13.7%) |
| ≥70 | 21 (3.6%) |
| FIGO stage | |
| IIIA | 31 (5.3%) |
| IIIB | 142 (24.2%) |
| IIIC1 | 325 (55.5%) |
| IIIC2 | 88 (15.0%) |
| Histology | |
| Scc | 519 (88.6%) |
| non-Scc | 54 (9.2%) |
| unclear | 13 (2.2%) |
| Tumor size | |
| <4cm | 135 (23.1%) |
| ≥4cm | 432 (73.7%) |
| unclear | 19 (3.2%) |
| CCT | |
| yes | 483 (82.4%) |
| No | 103 (17.6%) |
Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; Scc, squamous cell carcinoma; CCT, concurrent chemotherapy.